Indian Immunologicals Limited - Company Profile

Q: Who are the current directors of Indian Immunologicals Limited?

The current directors of Indian Immunologicals Limited are Meeneshkumar Champaklal Shah, Appalaraja Sekhar Ganasala, Rajeev Sivarama, Anand Kumar Kanakasapapathy, Usha Ramachandra, Devanand Chakkingal Pathayapura, Venkateswara Rao Thallapaka, Sanjay Madhav Mehendale, Shuchi Sharma.

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 1999.

1999 Hyderabad, Telangana, India Active

Last Updated: January 05, 2026

Access Report

About Indian Immunologicals Limited

Indian Immunologicals Limited, a active public limited company, was established on 08 October 1999 in Hyderabad, Telangana, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U72200TG1999PLC032666. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹400.00 Cr and a paid-up capital of ₹54.00 Cr.

It upholds a compliant status. Its leadership includes Meeneshkumar Champaklal Shah (Director), Rajeev Sivarama (Director), Anand Kumar Kanakasapapathy (Managing Director). Past directors included Balasubramaniam Venkatasubramaniam Kollengode, Deepak Tikku, Villuppanoor Alwar Srinivasan. It holds ₹335.16 Cr open charges and ₹887.42 Cr settled loans. Its latest AGM occurred on 12 September 2025, with the balance sheet filed on 31 March 2025. It is based at Indian Immunologicals Limited, Road No. 44, Jubilee Hills, Hyderabad, Telangana, 500033.

Company Details

CIN/LLPIN
U72200TG1999PLC032666
Registration Number
032666
Incorporation Date
08 October 1999
Authorized Capital
₹400.00 Cr
Paid-Up Capital
₹54.00 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 400.00 Cr as on 05-01-2026
Paid Up Capital ₹ 54.00 Cr as on 05-01-2026
Company Age 26 Year, 4 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 335.16 Cr as on 05-01-2026
Satisfied Charges ₹ 887.42 Cr as on 05-01-2026
Revenue Growth **** 9.74% (FY 2022)
Profit Growth **** 239.81% (FY 2022)
Ebitda **** 164.63% (FY 2022)
Net Worth 25.26% (FY 2022)
Total Assets **** 8.79% (FY 2022)

Comprehensive Company Insights

Explore comprehensive insights into Indian Immunologicals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Indian Immunologicals Limited?

Current Directors

Name	Designation	Appointment Date	Status
Meeneshkumar Champaklal Shah	Director	15 Jul 2021	Current
Rajeev Sivarama	Director	06 Aug 2021	Current
Anand Kumar Kanakasapapathy	Managing Director	01 Nov 2013	Current
Usha Ramachandra	Director	18 Mar 2025	Current
Devanand Chakkingal Pathayapura	Director	12 Nov 2021	Current
Venkateswara Rao Thallapaka	Director	18 Mar 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Managing Director	31 Mar 2016	Past
Pramod Abcsdd	Director	25 Sep 2014	Past
Pramod Abcsdd	Director	30 Jul 2021	Past
Pramod Abcsdd	Director	15 Apr 2014	Past
Pramod Abcsdd	Director	09 Oct 2014	Past
Pramod Abcsdd	Additional Director	20 Sep 2021	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Indian Immunologicals.

Indian Immunologicals Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.74% increase. The company also saw a substantial improvement in profitability, with a 239.81% increase in profit. The company's net worth Soared by an impressive increase of 25.26%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

9.74%

*******

Revenue from Operations

*******

8.80%

*******

Total Assets

*******

8.79%

*******

Profit or Loss

*******

239.81%

*******

Net Worth

*******

25.26%

*******

EBITDA

*******

164.63%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Indian Immunologicals?

In 2023, Indian Immunologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹3,351,600,000.00

Satisfied Charges

₹8,874,185,000.00

Charges Breakdown by Lending Institutions

Others : 215.16 Cr
Hdfc Bank Limited : 120.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
05 May 2016	Others	₹5.00 Cr	Open
18 Mar 2016	Others	₹85.16 Cr	Open
12 Dec 2013	Others	₹40.00 Cr	Open
14 Dec 2011	Others	₹85.00 Cr	Open
02 Sep 2010	Hdfc Bank Limited	₹120.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Indian Immunologicals?

Unlock and access historical data on people associated with Indian Immunologicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Indian Immunologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indian Immunologicals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Indian Immunologicals

Recent Activity within the Organization

Annual General Meeting

Progress on Indian Immunologicals Limited last Annual general meeting of members was held on 12 Sep 2025 as per latest MCA records. was documented.
12 Sep 2025
Balance Sheet

The activity Indian Immunologicals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
31 Mar 2025
Director Appointment

The activity Usha Ramachandra was appointed as a Director was appointed as a Director on 18 Mar 2025 & has been associated with this company since 11 months 1 day . was completed.
18 Mar 2025
Director Appointment

Venkateswara Rao Thallapaka was appointed as a Director was appointed as a Director on 18 Mar 2025 & has been associated with this company since 11 months 1 day . was recorded as a recent event.
18 Mar 2025
Charges

Progress on A charge with Others of Rs. 5.00 Cr registered on 05 May 2016 with Charge ID 100031486 was modified on 05 Mar 2025. was documented.
05 Mar 2025
Charges

Progress on A charge with Others of Rs. 85.00 Cr registered on 14 Dec 2011 with Charge ID 10327282 was modified on 05 Mar 2025. was documented.
05 Mar 2025

Explore recent activity and updates - View Recent Activity